GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Clinical trial NCT06265025 · RECRUITING

Trial details

NCT number: NCT06265025
Sponsor: GeneMedicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Malignant Melanoma Colorectal Cancer Renal Cell Carcinoma Cervical Cancer Breast Cancer

Start date: 2024-02-20
Primary completion: 2025-05-30
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.